RT @UCSFmac: 18 F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Limited sensitivity and specificity in patients with…
RT @UCSFmac: 18 F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Limited sensitivity and specificity in patients with…
18 F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Limited sensitivity and specificity in patients with FTD and predicted tauopathy or TDP-43 pathology. https://t.co/A9rOSpV5ki @RabLab_UCSF @lee_suzee @SalvoSpinaSF @grinberg_t @AlbaL
RT @UCSFmac: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. 18F-flortaucipir in patients with FTD and predicted t…
RT @UCSFmac: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. 18F-flortaucipir in patients with FTD and predicted t…
RT @UCSFmac: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. 18F-flortaucipir in patients with FTD and predicted t…
RT @UCSFmac: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. 18F-flortaucipir in patients with FTD and predicted t…
RT @UCSFmac: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. 18F-flortaucipir in patients with FTD and predicted t…
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. 18F-flortaucipir in patients with FTD and predicted tauopathy or TDP-43 pathology demonstrated limited sensitivity and specificity. Pathology & tau-specific ligands needed. https:
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @pjbrannelly: Tau Consortium researchers and their colleagues show an unmet need for Tau PET tracers in frontotemporal dementia. https:/…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @pjbrannelly: Tau Consortium researchers and their colleagues show an unmet need for Tau PET tracers in frontotemporal dementia. https:/…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
A very good validation indeed!
RT @pjbrannelly: Tau Consortium researchers and their colleagues show an unmet need for Tau PET tracers in frontotemporal dementia. https:/…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
Tau Consortium researchers and their colleagues show an unmet need for Tau PET tracers in frontotemporal dementia.
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
RT @RikOssenkoppele: Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with front…
Important paper confirming that Flortaucipir (#tau) PET has limited sensitivity and specificity in patients with frontotemporal dementia (#FTD). On the bright side: this enhances the diagnostic performance in #Alzheimer's disease. https://t.co/3U7D0sGniF @
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. - PubMed - NCBI https://t.co/7n6YyD7dFs